Should the FDA mandate that autologous units drawn and transfused within asingle institution be tested for markers of infectious disease?

Perkins, J Kaminer, L Kruskall, M Cannon, M Uhl, L Dzik, W Silver, H O'Neill, M Popovsky, M King, K Ness, P AuBuchon, J Shapiro, A Yomtovian, R Petz, LD

J. Perkins et al., Should the FDA mandate that autologous units drawn and transfused within asingle institution be tested for markers of infectious disease?, TRANSFUSION, 40(6), 2000, pp. 752-754

3

Hematology,"Cardiovascular & Hematology Research

TRANSFUSION

00411132 → ACNP

40

6

2000

752 - 754

ISI

0041-1132(200006)40:6<752:STFMTA>2.0.ZU;2-M